This article was originally published in The Rose Sheet
Edward Lonergan to president, commercial operations, Europe effective May 15, company announces. Former Procter & Gamble exec will be responsible for sales, marketing, category management and trade relations for Gillette line in Europe, company says. Lonergan, who worked for P&G for 20 years, most recently headed a global team managing one of the firm's largest customers operating in 28 countries, Gillette says...
You may also be interested in...
In a statement submitted to the Senate Finance Committee, Natural Products Association CEO Dan Fabricant suggests two ways of improving compliance with new dietary ingredient notification requirements at negligible expense to the US FDA.
Public Company Edition: Legend Biotech raised $424m in its US public market debut. Also, Pfizer commits up to $500m for equity investments and Allogene capitalizes on ASCO with a $550m offering.
US FDA investigators are more likely to cite cell and gene therapy manufacturers for facilities and production deficiencies, agency says, while industry reports difficulties complying with drug GMP requirements that are not always applicable to cell and gene therapies.